| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/29/2006 | WO2006067847A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited |
| 06/29/2006 | WO2006067613A1 Compositions and methods for expression and purification of fatty acid amide hydrolase |
| 06/29/2006 | WO2006067565A2 Truncated gabab receptor and methods of use thereof |
| 06/29/2006 | WO2006067511A1 Gene expression technique |
| 06/29/2006 | WO2006067506A2 Hiv resistance genes |
| 06/29/2006 | WO2006067487A2 Use of cytochrome p450 reductase as insecticidal target |
| 06/29/2006 | WO2006067465A2 Cancer treatment |
| 06/29/2006 | WO2006067402A2 Agents inibiting the cathelin-like protein cap18/ll-37 |
| 06/29/2006 | WO2006067322A2 In-vitro method for producing oocytes or eggs having targeted genomic modification |
| 06/29/2006 | WO2006067236A1 Plants having increased yield and method for making the same |
| 06/29/2006 | WO2006067219A1 Methods and means to increase the amounts of carbohydrates in plants |
| 06/29/2006 | WO2006067210A1 Bcma polypeptides and uses thereof |
| 06/29/2006 | WO2006066969A2 Sugarcane plants with an increased storage carbohydrate content |
| 06/29/2006 | WO2006066959A1 Fusion proteins and methods for determining protein-protein-interactions in living cells and cell lysates, nucleic acids encoding these fusion proteins, as well as vectors and kits containing these |
| 06/29/2006 | WO2006066925A2 Novel genes involved in gluconeogenesis |
| 06/29/2006 | WO2006066859A1 Nucleic acid molecules encoding kcs-like polypeptides and methods of use |
| 06/29/2006 | WO2006066758A1 Mutant of the prob gene from coryneform bacteria |
| 06/29/2006 | WO2006066599A2 Mas related g protein coupled receptors as drug targets |
| 06/29/2006 | WO2006066596A2 Hybrid enzymes consisting of an endo-amylase first amino acid sequence and a carbohydrate -binding module as second amino acid sequence |
| 06/29/2006 | WO2006066595A2 Recombinant production of serum albumin |
| 06/29/2006 | WO2006066498A1 The transcription factor gene osnacx from rice and use for improving tolerance of plants to drought and salt thereof |
| 06/29/2006 | WO2006066463A1 Receptor-selective lymphotoxin deviants |
| 06/29/2006 | WO2006066441A1 A fibrinolysin of agkistrodon acutus venom and its usage |
| 06/29/2006 | WO2006066408A1 Cancer specific antibody and cell surface proteins |
| 06/29/2006 | WO2006066368A1 Method for screening and selecting ligands |
| 06/29/2006 | WO2006066358A1 Vacuole targeting peptide and nucleic acid |
| 06/29/2006 | WO2006066355A1 Chitin-binding peptides |
| 06/29/2006 | WO2006066353A1 Detection of human papilloma virus |
| 06/29/2006 | WO2006066340A1 A method for the high expression of immunoglobulin in plants |
| 06/29/2006 | WO2006054326A3 Animal model for studying substances with cardiotherapeutic and anti-hypertensive activity |
| 06/29/2006 | WO2006042558A3 Group 2 mite polypeptide variants |
| 06/29/2006 | WO2006042112A9 Aptamer regulated nucleic acids and uses thereof |
| 06/29/2006 | WO2006040129A3 Ubiquitin or gamma-crystalline conjugates for use in therapy, diagnosis and chromatography |
| 06/29/2006 | WO2006037421A3 Immunogenic t-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes |
| 06/29/2006 | WO2006037327A3 Polypeptides having phytase activity and polynucleotides encoding same |
| 06/29/2006 | WO2006036834A3 MODIFIED Fc MOLECULES |
| 06/29/2006 | WO2006035442A8 Collagen producing plants and methods of generating and using same |
| 06/29/2006 | WO2006027468A3 Hla-dp4 restricted t cd4+ du vih epitopes and the use thereof |
| 06/29/2006 | WO2006025990A3 Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use |
| 06/29/2006 | WO2006023420A3 Integrin antagonists with enhanced antibody dependent cell-mediated cytotoxicity activity |
| 06/29/2006 | WO2006019804A3 Compositions and methods of purifying myelin-associated glycoprotein (mag) |
| 06/29/2006 | WO2006015887A3 Modulation of alkaloid biosynthesis in plants and plants having altered alkaloid biosynthesis |
| 06/29/2006 | WO2006012985A3 Method for production of transgenic plants with increased pathogenic resistance by altering the content and/or activity of actin-depolymerising factors |
| 06/29/2006 | WO2006005740A3 P75ntr screening assay for indentifying modulators of apoptosis |
| 06/29/2006 | WO2006002643A3 Alpha-amylase variants with altered properties |
| 06/29/2006 | WO2005118823A3 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| 06/29/2006 | WO2005118790A3 Combinatorial marking of cells and cell structures with reconstituted fluorescent proteins |
| 06/29/2006 | WO2005116061A3 Sequences for the synthesis of antibacterial polyketides |
| 06/29/2006 | WO2005115480A3 Modified protein kinase a-specific oligonucleotides and methods of their use |
| 06/29/2006 | WO2005112886A3 Methods and articles for the delivery of therapeutic agents |
| 06/29/2006 | WO2005110338A3 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 06/29/2006 | WO2005095652A3 Pnmt as a novel marker for progenitor cells |
| 06/29/2006 | WO2005087793A3 Immunostimulatory compositions and uses thereof |
| 06/29/2006 | WO2005080417A3 Recombinant viruses with heterologous envelope proteins |
| 06/29/2006 | WO2005019242A8 Recombinant expression of the hag1 antimicrobial peptide: use as fusion partner for the expression of alpha helical antimicrobial peptides |
| 06/29/2006 | WO2005017100A3 Ribonucleases and methods of making them recombinantly |
| 06/29/2006 | WO2005015154A3 Autocatalysis/yeast two-hybrid assay |
| 06/29/2006 | WO2005010016A3 Thioaptamers enable discovery of physiological pathways and new therapeutic strategies |
| 06/29/2006 | WO2005001092A3 Compositions and methods for diagnosing and treating cancers |
| 06/29/2006 | WO2005001050A3 Transcription factors |
| 06/29/2006 | WO2004089292A3 Immunomodulatory agents for treatment of inflammatory diseases |
| 06/29/2006 | WO2004066935A3 Sensitive proteasome sensor constructs and methods for their design and use |
| 06/29/2006 | WO2003093444A3 Transporters and ion channels |
| 06/29/2006 | WO2003091413A3 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same |
| 06/29/2006 | US20060143744 Inbred corn line PHEED |
| 06/29/2006 | US20060143739 Useful for modulating transcription of a desired polynucleotide; expression cassette or vector, or inserted into the chromosome or used as an exogenous element to modulate in vivo and in vitro; transgenic plant has increased biomass or higher seed yield |
| 06/29/2006 | US20060143738 Proteases and methods for producing them |
| 06/29/2006 | US20060143737 Useful for conditional or regulated gene silencing in plants, comprising a suite of constitutive, inducible, tissue-specific or developmental stage-specific promoters operably linked to target sequences |
| 06/29/2006 | US20060143736 Modulating plant carbon levels |
| 06/29/2006 | US20060143735 Root active promoters and uses thereof |
| 06/29/2006 | US20060143734 For transfecting a plant cell, transgenic plant |
| 06/29/2006 | US20060143732 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes |
| 06/29/2006 | US20060143730 Controlling gene expression of plastids; encoding acetolactate synthase ; herbide resistance to plants; detction targte genes |
| 06/29/2006 | US20060143729 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| 06/29/2006 | US20060143728 Maize multidrug resistance-associated protein polynucleotides and methods of use |
| 06/29/2006 | US20060143727 Glyphosate resistant class i 5-enolpyruvylshikimate-3-phosphate synthase(epsps) |
| 06/29/2006 | US20060143726 Hydroxypyruvate reductase promoter elements and methods of use thereof in plants |
| 06/29/2006 | US20060143725 Method of expressing gene in transgenic birds using retrovirus vector and transgenic birds thus obtained |
| 06/29/2006 | US20060143724 Transgenic mice containing anaphylatoxin C3a gene disruptions |
| 06/29/2006 | US20060143722 OGR1 gene disruptions, compositions and methods relating thereto |
| 06/29/2006 | US20060143721 Transgenic mice containing tryptase gene disruptions |
| 06/29/2006 | US20060143720 Transgenic mice containing chordin gene disruptions |
| 06/29/2006 | US20060142557 2'-deoxy-2'alkylnucleotide containing nucleic acid |
| 06/29/2006 | US20060142556 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides |
| 06/29/2006 | US20060142548 Methods of identifying and designing cell surface receptor inhibitors |
| 06/29/2006 | US20060142547 Anktm1, a cold-activated trp-like channel expressed in nociceptive neurons |
| 06/29/2006 | US20060142236 Antisense oligonucleotide modulation of raf gene expression |
| 06/29/2006 | US20060142230 Double-stranded ribonucleic acid molecules having ribothymidine |
| 06/29/2006 | US20060142229 Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereof |
| 06/29/2006 | US20060142228 Methods and compositions concerning siRNA's as mediators of RNA interference |
| 06/29/2006 | US20060142225 siNA molecule comprising a double-stranded structure that down-regulates expression of cyclin dependent kinase-2 (CDK2) , wherein said siNA molecule does not require the presence of nucleotides having a 2'-hydroxy group within the siNA molecule for mediating RNA interference |
| 06/29/2006 | US20060142224 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 06/29/2006 | US20060142223 Methods for xenotopic expression of nucleus-encoded plant and protist peptides and uses thereof |
| 06/29/2006 | US20060142221 Vaccine |
| 06/29/2006 | US20060142219 Pharmaceutical compositions comprising an hiv envelope protein and cd4 |
| 06/29/2006 | US20060142218 Method of controlling telomere length |
| 06/29/2006 | US20060142200 Compounds and methods for lowering cholesterol levels without inducing hypertrigylceridemia |
| 06/29/2006 | US20060142199 CD-44 like protein |
| 06/29/2006 | US20060142196 Soluble GDNFR (Glial-cell Derived Neurotrophic Factor) that retains both ligand binding, and receptor signaling function (via Ret receptor tyrosine kinase) used to impart, restore, or enhance GDNFR alpha -ligand (preferably GDNF) responsiveness to cells; kidney diseases |
| 06/29/2006 | US20060142188 Monkey alpha-7 nicotinic acetylcholine receptor and methods of use thereof |